Plasma proteomic profiling identifies CD33 as a marker of HIV control in natural infection and after therapeutic vaccination

BACKGROUND: Biomarkers predicting the outcome of HIV-1 virus control in natural infection and after therapeutic interventions in HIV-1 cure trials remain poorly defined. The BCN02 trial (NCT02616874), combined a T-cell vaccine with romidepsin (RMD), a cancer-drug that was used to promote HIV-1 laten...

Descripción completa

Detalles Bibliográficos
Autores principales: Duran-Castells, Clara, Prats, Anna, Oriol-Tordera, Bruna, Llano, Anuska, Galvez, Cristina, Martinez-Picado, Javier, Ballana, Ester, Garcia-Vidal, Edurne, Clotet, Bonaventura, Muñoz-Moreno, Jose A., Hanke, Thomas, Moltó, José, Mothe, Beatriz, Brander, Christian, Ruiz-Riol, Marta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410179/
https://www.ncbi.nlm.nih.gov/pubmed/37506557
http://dx.doi.org/10.1016/j.ebiom.2023.104732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10410179/
https://www.ncbi.nlm.nih.gov/pubmed/37506557
http://dx.doi.org/10.1016/j.ebiom.2023.104732

Ejemplares similares